ArticleProceedings of the National Academy of Sciences of the United States of America2024
Open access · hybridAbstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 25 citations in OpenAlex.
- Article
- Eosinophil Extracellular Traps in Health and Disease: From Host Defense to Chronic Inflammation.Biomedicines · 2026Review
- The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response.Experimental dermatology · 2026Article
- Keratinocytes: pleiotropic orchestrators of cutaneous immunity and Inflammation - Emerging therapeutic paradigms in dermatological pathologies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Review
- Atopic march protocol involving sequential skin and lung inflammation elicited by epicutaneous Staphylococcus aureus and allergen exposure.STAR protocols · 2026Article
- Molecular Dynamics Simulations and Current Trends in Designing New Antivirals Targeting Proteases: A Review from 2018 to 2025.Current drug targets · 2026Review
- Review
- Chemokine ligand-receptor interactions as potential therapeutic targets for atopic dermatitis: from basic to clinical research.Frontiers in allergy · 2026Review
- Bacterial and fungal co-colonization altersFrontiers in microbiology · 2026Article
- Case Report: Paradoxical psoriasis under TNF-α blockade may represent generalized abscessing staphyloderma - GASD syndrome by TNF antagonists.Frontiers in immunology · 2026Article
- Honokiol-loaded nanoparticles for targeted bacterial eradication and treatment of MRSA infection.Materials today. Bio · 2025Article
- Kaempferol and Kaempferin Alleviate MRSA Virulence by Suppressing β-Lactamase and Inflammation.Molecules (Basel, Switzerland) · 2025Article
- Atopic dermatitis in inborn errors of immunity: at the interface of immunodeficiency and immune dysregulation.Immunologic research · 2025Review
- Epicutaneous Staphylococcus aureus initiates cross-tissue IL-36R signaling for neutrophilic lung inflammation in a model of the atopic march.Cell reports · 2025Article
- Immune dysfunction during S. aureus biofilm-associated implant infections: opportunities for novel therapeutic strategies.NPJ biofilms and microbiomes · 2025Review
- Review
- A Conceptual Review of Gut, Skin, and Oral Microbiota in Autoimmune Bullous Diseases: From Dysbiosis to Therapeutic Potential.Journal of inflammation research · 2025Review
- Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment.Frontiers in medicine · 2025Article
- CommensalFrontiers in immunology · 2025Article
- Immunomodulatory and anti-inflammatory effects of agave fructans in atopic dermatitis: gut microbiota and short-chain fatty acid implication.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 5 institutions in 2 countries.
Sabrina N Kline *Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0001-8213-3621
Nicholas A Orlando *Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0002-3999-4845
Alex J LeeDepartment of Oncology, Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD 21205.ORCID 0000-0002-1825-2439
Meng-Jen WuDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0003-2303-0563
Jing ZhangDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0009-0004-4533-6461
Christine YounDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
Laine E FellerDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0002-1328-6090
Cristina PontazaDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
Dustin DikemanDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0003-1716-1479
Nathachit LimjunyawongCenter of Research Excellence in Allergy and Immunology, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.ORCID 0000-0002-9540-6171
Kaitlin L WilliamsDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0002-8768-0488
Yu WangDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
Daniela CihakovaDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
Elizabeth A JacobsenDivision of Allergy, Asthma and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ 85259.ORCID 0000-0003-2956-753X
Scott K DurumCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702.
Luis A GarzaDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0002-6547-9695
Xinzhong DongHHMI, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Nathan K ArcherDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.ORCID 0000-0002-8212-8985
Johns Hopkins University · USBloomberg (United States) · USNational Cancer Institute · USSiriraj Hospital · THWinnMed · US
Funding
Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4MMultivalent Toxoid Vaccine for recurrent Staphylococccus aureus diseaseR01AI111205 · NIAID · INTEGRATED BIOTHERAPEUTICS, INC. · PI M Javad Aman · 2015 to 2026
$6.9MProtective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infectionR01AI146177 · NIAID · INTEGRATED BIOTHERAPEUTICS, INC. · PI AMAN, M JAVAD, ARCHER, NATHAN K. · 2020 to 2024
$3.5MIL-36 responses in Staphylococcus aureus driven skin inflammationR01AR073665 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2018 to 2022
$1.8MSTAT3-mediated immunity to Staphylococcus aureus in skinR01AR069502 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2016 to 2020
$1.8MFuture Academic Scientists in DermatologyT32AR074920 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Luis Andres Garza · 2020 to 2026
$1.4MNIAID NIH HHS R01 AI111205NIAID NIH HHS R01 AI146177NIAMS NIH HHS R01 AR069502NIAMS NIH HHS R01 AR073665NIAMS NIH HHS T32 AR074920NIGMS NIH HHS T32 GM136577
Abstract
PubMed holds no abstract for this paper.
Indexed as
Dermatitis, AtopicEosinophiliaStaphylococcal InfectionsAnimalsCellulitisEosinophilsInflammationMicePeptide HydrolasesSkinStaphylococcus aureusPeptide Hydrolaseseosinophilsinflammatory skin diseasesinterleukin-17interleukin-36Staphylococcus aureus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.